Tiotropium matching placebo

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 3

A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease

CompletedNCT02207829

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2014-09-01End: 2015-06-15Updated: 2018-01-24

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

CompletedNCT02257385

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2014-10-15End: 2015-05-04Updated: 2018-03-01

Related Papers

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective.

2018-05-102 citations

Inhaler preference comparing two alternative dual bronchodilator regimens

2016-09-01

Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.

2016-06-0120 citations